NEW TAIPEI CITY, Taiwan — Nov. 15, 2025 — Winnoz Technology, Inc., a developer of minimally invasive blood microsampling devices, today announced the launch of Haiim® PLUS, its next-generation, CE-marked fingertip blood collection system.

The device, which can collect up to 1,000 µL (1.0 mL) of high-quality capillary blood from a fingertip, will make its public debut at the MEDICA 2025 trade fair in Düsseldorf, Germany, from Nov. 17–20.

The launch addresses a global shift toward decentralized care, a trend accelerated by aging populations, rising test demand, and phlebotomy workforce constraints. The Haiim® system is designed to empower non-traditional testing sites—such as pharmacies, clinics, and mobile services—by streamlining blood collection into a safe, comfortable, and accessible process.

Building on the original Haiim® platform, the Haiim® PLUS introduces an enhanced internal mechanism and a redesigned “Cassette-X™.” These improvements increase the typical blood yield from the original’s 250-500 µL to a new range of 500-1,000 µL. The company notes this allows collection of up to ~1,000 µL with Greiner MiniCollect® tubes and up to ~600 µL with BD Microtainer® tubes.

The larger volume significantly broadens the device’s diagnostic capabilities. It supports compatibility with a wider array of point-of-care testing (POCT) analyzers and enables more extensive laboratory diagnostic panels, including multi-parameter testing across clinical chemistry and hematology.